Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 23, 2023Antimicrobial Agents and ChemotherapyOpen Access

Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

DNDereje A. NegatuAIDS Clinical Trials GroupRRRubén González del RíoUniversity of British ColumbiaMCMónica CachoGlaxoSmithKline (Spain)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Negatu et al. (2023) studied this question.

synapsesocial.com/papers/6a9511cf5f3b0bfa3be62285https://doi.org/10.1128/aac.01459-22
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease2022 · 29 citations
  2. 2Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill2019 · 50 citations
  3. 3Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection2022 · 78 citations